Janney Montgomery Scott
TEVA icon

Janney Montgomery Scott’s Teva Pharmaceuticals TEVA Stock Holding History

Janney Montgomery Scott’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.9M Sell
2,121,721
-20,036
-0.9% -$667K 0.14% 150
2026
Q1 		$64.5M Sell
2,141,757
-4,280
-0.2% -$138K 0.16% 138
2025
Q4 		$67M Sell
2,146,037
-27,936
-1% -$688K 0.15% 137
2025
Q3 		$43.9M Buy
2,173,973
+103,119
+5% +$1.81M 0.1% 192
2025
Q2 		$34.7M Sell
2,070,854
-8,427
-0.4% -$136K 0.09% 219
2025
Q1 		$32M Buy
2,079,281
+588,295
+39% +$10.5M 0.09% 220
2024
Q4 		$32.9M Buy
1,490,986
+90,661
+6% +$1.65M 0.09% 212
2024
Q3 		$25.2M Buy
1,400,325
+17,545
+1% +$307K 0.07% 279
2024
Q2 		$22.5M Buy
1,382,780
+10,303
+0.8% +$159K 0.07% 285
2024
Q1 		$19.4M Buy
1,372,477
+164,614
+14% +$2.07M 0.06% 337
2023
Q4 		$12.6M Buy
1,207,863
+389,136
+48% +$3.63M 0.04% 432
2023
Q3 		$8.35M Buy
818,727
+6,407
+0.8% +$59.7K 0.03% 497
2023
Q2 		$6.12M Sell
812,320
-23,804
-3% -$193K 0.02% 620
2023
Q1 		$7.4M Sell
836,124
-6,440
-0.8% -$63.7K 0.03% 510
2022
Q4 		$7.68M Sell
842,564
-49,038
-5% -$428K 0.03% 518
2022
Q3 		$7.2M Sell
891,602
-1,288
-0.1% -$11.4K 0.03% 494
2022
Q2 		$6.99M Buy
892,890
+26,013
+3% +$227K 0.03% 477
2022
Q1 		$8.14M Buy
866,877
+37,565
+5% +$313K 0.03% 439
2021
Q4 		$6.64M Buy
829,312
+38,212
+5% +$345K 0.03% 534
2021
Q3 		$7.71M Buy
791,100
+31,162
+4% +$292K 0.03% 455
2021
Q2 		$7.52M Buy
759,938
+15,640
+2% +$166K 0.03% 451
2021
Q1 		$8.59M Buy
744,298
+274,909
+59% +$3.15M 0.04% 370
2020
Q4 		$4.53M Buy
469,389
+168,651
+56% +$1.62M 0.02% 570
2020
Q3 		$2.71M Buy
300,738
+23,413
+8% +$248K 0.02% 683
2020
Q2 		$3.42M Buy
277,325
+225,951
+440% +$2.56M 0.02% 575
2020
Q1 		$461K Buy
51,374
+29,169
+131% +$299K ﹤0.01% 1259
2019
Q4 		$218K Sell
22,205
-12,128
-35% -$108K ﹤0.01% 1880
2019
Q3 		$236K Sell
34,333
-63,284
-65% -$485K ﹤0.01% 1808
2019
Q2 		$901K Sell
97,617
-52,501
-35% -$633K 0.01% 1106
2019
Q1 		$2.35M Buy
150,118
+3,208
+2% +$56.6K 0.02% 641
2018
Q4 		$2.27M Sell
146,910
-17,030
-10% -$349K 0.02% 602
2018
Q3 		$3.53M Sell
163,940
-45,020
-22% -$1.05M 0.03% 507
2018
Q2 		$5.08M Buy
208,960
+10,533
+5% +$215K 0.05% 375
2018
Q1 		$3.39M Sell
198,427
-10,836
-5% -$212K 0.03% 475
2017
Q4 		$3.97M Sell
209,263
-34,670
-14% -$522K 0.04% 423
2017
Q3 		$4.29M Sell
243,933
-105,797
-30% -$2.38M 0.05% 371
2017
Q2 		$11.6M Buy
349,730
+46,398
+15% +$1.44M 0.15% 168
2017
Q1 		$9.73M Buy
303,332
+47,809
+19% +$1.63M 0.13% 190
2016
Q4 		$9.26M Buy
255,523
+36,314
+17% +$1.45M 0.14% 183
2016
Q3 		$10.1M Sell
219,209
-209,631
-49% -$10.9M 0.18% 132
2016
Q2 		$21.5M Buy
428,840
+256,332
+149% +$13.6M 0.44% 58
2016
Q1 		$9.23M Buy
172,508
+3,335
+2% +$196K 0.24% 100
2015
Q4 		$11.1M Buy
169,173
+17,718
+12% +$1.09M 0.29% 83
2015
Q3 		$8.55M Sell
151,455
-3,741
-2% -$243K 0.24% 103
2015
Q2 		$9.17M Buy
155,196
+1,466
+1% +$90.4K 0.19% 120
2015
Q1 		$9.58M Sell
153,730
-1,780
-1% -$103K 0.18% 136
2014
Q4 		$8.94M Sell
155,510
-4,706
-3% -$262K 0.18% 126
2014
Q3 		$8.61M Buy
160,216
+14,914
+10% +$790K 0.18% 127
2014
Q2 		$7.62M Buy
145,302
+5,275
+4% +$270K 0.17% 134
2014
Q1 		$7.4M Buy
140,027
+24,901
+22% +$1.15M 0.18% 128
2013
Q4 		$4.61M Buy
115,126
+11,220
+11% +$442K 0.12% 194
2013
Q3 		$3.93M Buy
103,906
+78,510
+309% +$3.06M 0.12% 205
2013
Q2 		$996K Buy
+25,396
New +$989K 0.1% 230

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Janney Montgomery Scott's TEVA Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Teva Pharmaceuticals (TEVA) stake by 0.94% in Q2 2026, selling an estimated $667K and leaving 2,121,721 shares worth $71.9M. The position accounts for 0.14% of the portfolio, ranked #150.

Janney Montgomery Scott first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Janney Montgomery Scott held 2,121,721 shares of Teva Pharmaceuticals worth $71.9M as of Q2 2026.
  • Janney Montgomery Scott sold 20,036 Teva Pharmaceuticals shares in Q2 2026, an estimated $667K.
  • Teva Pharmaceuticals made up 0.14% of Janney Montgomery Scott's portfolio in Q2 2026, its #150 holding.
  • Janney Montgomery Scott first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.